KaramjeetSinghSandhuMD
Hematology • Duarte, CAHematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor
Dr. Sandhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Dept of Hematology Hematopoietic Cell Transplantation
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-301-8116
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2012 - 2015
Hennepin HealthcareResidency, Internal Medicine, 2009 - 2012
Tver State Medical AcademyClass of 2000
Certifications & Licensure
CA State Medical License 2014 - 2026
MN State Medical License 2014 - 2016
Clinical Trials
- Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant Start of enrollment: 2021 Apr 30
Roles: Principal Investigator, Contact
- Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML Start of enrollment: 2021 Nov 24
Roles: Contact
- Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2023 Sep 18
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsCrenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland B Walter, Chatchada Karanes
Journal of Clinical Oncology. 2024-05-20 - 64 citationsThe MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host diseaseHrishikesh K. Srinagesh, Umut Ozbek, Urvi Kapoor, Francis Ayuk, Mina Aziz
Blood Advances. 2019-12-10 - 8 citationsIncidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD.Yu Akahoshi, Nikolaos Spyrou, William J Hogan, Francis Ayuk, Zachariah DeFilipp
Blood Advances. 2023-08-22
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseKaramjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Karamjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021- Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood CancersNovember 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
